Ines Kozar

641 total citations
9 papers, 441 citations indexed

About

Ines Kozar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ines Kozar has authored 9 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Immunology. Recurrent topics in Ines Kozar's work include Melanoma and MAPK Pathways (4 papers), interferon and immune responses (2 papers) and CAR-T cell therapy research (2 papers). Ines Kozar is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), interferon and immune responses (2 papers) and CAR-T cell therapy research (2 papers). Ines Kozar collaborates with scholars based in Luxembourg, Germany and United States. Ines Kozar's co-authors include Stephanie Kreis, Christiane Margue, Claude Haan, Jochen Utikal, Demetra Philippidou, Giulia Cesi, Iris Behrmann, Elisabeth Letellier, Paul Felten and Andreas Zimmer and has published in prestigious journals such as Molecular Cancer, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Ines Kozar

9 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ines Kozar Luxembourg	8	319	185	112	93	45	9	441
Suzanne Egyházi Brage Sweden	13	316 1.0×	244 1.3×	87 0.8×	193 2.1×	38 0.8×	18	568
Kate Hogan United Kingdom	4	237 0.7×	163 0.9×	103 0.9×	64 0.7×	50 1.1×	10	388
Paola Corazao-Rozas France	5	302 0.9×	101 0.5×	125 1.1×	51 0.5×	36 0.8×	5	405
Saketh S. Dinavahi United States	11	222 0.7×	136 0.7×	135 1.2×	82 0.9×	33 0.7×	17	409
Haiyan Cai China	14	408 1.3×	270 1.5×	46 0.4×	154 1.7×	27 0.6×	35	687
Bettina Miller United States	10	230 0.7×	172 0.9×	115 1.0×	72 0.8×	34 0.8×	14	404
Tammy Sobolik United States	8	210 0.7×	213 1.2×	40 0.4×	103 1.1×	56 1.2×	9	386
Heike Helmbach Germany	8	456 1.4×	163 0.9×	60 0.5×	93 1.0×	34 0.8×	8	548
Yuzhu Zheng China	10	275 0.9×	129 0.7×	59 0.5×	46 0.5×	47 1.0×	15	450
Sumit Das India	5	283 0.9×	175 0.9×	123 1.1×	58 0.6×	22 0.5×	6	468

Countries citing papers authored by Ines Kozar

Since Specialization

Citations

This map shows the geographic impact of Ines Kozar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Kozar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Kozar more than expected).

Fields of papers citing papers by Ines Kozar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Kozar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Kozar. The network helps show where Ines Kozar may publish in the future.

Co-authorship network of co-authors of Ines Kozar

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Kozar. A scholar is included among the top collaborators of Ines Kozar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Kozar. Ines Kozar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kozar, Ines, et al.. (2021). NRAS mutant melanoma: Towards better therapies. Cancer Treatment Reviews. 99. 102238–102238. 88 indexed citations

Kozar, Ines, Demetra Philippidou, Christiane Margue, et al.. (2021). Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells. Cancers. 13(5). 1096–1096. 15 indexed citations

Kozar, Ines. (2020). From drug resistance mechanisms to microRNA function in melanoma. Open Repository and Bibliography (University of Luxembourg). 1 indexed citations

Kozar, Ines, et al.. (2019). Many ways to resistance: How melanoma cells evade targeted therapies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(2). 313–322. 190 indexed citations

Margue, Christiane, Demetra Philippidou, Ines Kozar, et al.. (2019). Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells. Journal of Experimental & Clinical Cancer Research. 38(1). 56–56. 25 indexed citations

Cesi, Giulia, Demetra Philippidou, Ines Kozar, et al.. (2018). A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells. Molecular Cancer. 17(1). 145–145. 50 indexed citations

Kozar, Ines, Giulia Cesi, Christiane Margue, Demetra Philippidou, & Stephanie Kreis. (2017). Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(11). 2980–2992. 24 indexed citations

Rolvering, Catherine, Andreas Zimmer, Ines Kozar, et al.. (2016). Crosstalk between different family members: IL27 recapitulates IFNγ responses in HCC cells, but is inhibited by IL6-type cytokines. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(3). 516–526. 17 indexed citations

Haan, Claude, et al.. (2016). Phosphorylation of the PDH complex precedes HIF-1-mediated effects and PDK1 upregulation during the first hours of hypoxic treatment in HCC cells. PubMed. Volume 4. 135–145. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact